Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2025 Earnings Call Transcript November 12, 2025
Acurx Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.23, expectations were $-1.61.
Operator: Welcome to the Acurx Pharmaceuticals’ third quarter 2025 conference call and business update. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the...
